STOCK TITAN
  1. Home
  2. Sec-filings
  3. VTRS
  4. [ARS] Viatris Inc SEC Filing

[ARS] Viatris Inc SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.
ARS - Viatris Inc

ARS Filing - Viatris Inc

This filing is available as a PDF document.

Filing Type: ARS

Company: Viatris Inc (VTRS)

Acceptance Date: 2025-10-24T16:19:02.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock VTRS logo
Viatris Inc Ord Shs

NASDAQ:VTRS

VTRS Rankings

#827 Ranked by Market Cap
#711 Ranked by Dividends

VTRS Latest News

Oct 15, 2025
Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region
Oct 13, 2025
Viatris to Participate in Upcoming Investor Conferences
Oct 8, 2025
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fifth Year in a Row
Oct 1, 2025
Viatris to Report Third Quarter 2025 Financial Results on November 6, 2025
Aug 19, 2025
Viatris Appoints Andrew Enrietti as Chief Administrative and Transformation Officer

VTRS Latest SEC Filings

Oct 24, 2025
[8-K] Viatris Inc Reports Material Event
Oct 24, 2025
[DEF 14A] Viatris Inc Definitive Proxy Statement
Sep 11, 2025
[144] Viatris Inc. SEC Filing
Aug 19, 2025
[Form 4] Viatris Inc. Insider Trading Activity
Aug 19, 2025
[Form 3] Viatris Inc. Initial Statement of Beneficial Ownership

VTRS Stock Data

12.02B
1.16B
0.28%
85.61%
3.48%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG